Comparison Between Dexmedetomidine and Remifentanil on the Maternal Responses to Tracheal Intubation in Severe Pre-eclamptic Patients During Caesarean Delivery
Phase of Trial: Phase II
Latest Information Update: 31 Jan 2017
At a glance
- Drugs Dexmedetomidine (Primary) ; Remifentanil
- Indications Preeclampsia
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 19 Jan 2017 Status changed from recruiting to completed.
- 05 Feb 2016 Planned End Date changed from 1 Nov 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov record.